Prudential Financial’s Surface Oncology, Inc. Common Stock SURF Stock Holding History

Prudential Financial’s Portfolio SURF Stock Details SURF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-39,000	Closed	-$27.3K	–	2753
2023 Q1	$27.3K	Buy	39,000 +27,800	+248%	+$22.5K	﹤0.01%	2552
2022 Q4	$9.18K	Buy	+11,200	New	+$11K	﹤0.01%	2579
2022 Q2	–	Sell	-490,135	Closed	-$1.44M	–	2777
2022 Q1	$1.44M	Buy	490,135 +229,100	+88%	+$803K	﹤0.01%	1698
2021 Q4	$1.25M	Buy	261,035 +36,785	+16%	+$237K	﹤0.01%	1776
2021 Q3	$1.7M	Buy	224,250 +123,410	+122%	+$790K	﹤0.01%	1544
2021 Q2	$752K	Buy	+100,840	New	+$777K	﹤0.01%	1967

Other funds holding SURF

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

AVAI

Atlas Venture Associates IX Boston, Massachusetts $11.8M AUM 58.35% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

YCM

Yakira Capital Management Westport, Connecticut $342M AUM 26.97% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Prudential Financial's SURF Position: Q2 2023 in Review

Prudential Financial sold out of Surface Oncology, Inc. Common Stock (SURF) in Q2 2023, closing a stake of 39,000 shares — an estimated $27.3K sold.

Prudential Financial first reported a position in SURF in Q2 2021 and held it in 6 quarters. The position peaked at $1.7M in Q3 2021. 61 funds tracked by Wall St. Rank hold SURF as of Q2 2023.

Prudential Financial reported no remaining Surface Oncology, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Prudential Financial sold 39,000 Surface Oncology, Inc. Common Stock shares in Q2 2023, an estimated $27.3K.
Prudential Financial first reported a position in Surface Oncology, Inc. Common Stock in Q2 2021 and held it in 6 quarters.
Prudential Financial's Surface Oncology, Inc. Common Stock position peaked at $1.7M in Q3 2021.
61 funds tracked by Wall St. Rank held Surface Oncology, Inc. Common Stock as of Q2 2023.

Based on Prudential Financial's 13F filing for Q2 2023, filed 11 Aug 2023.